期刊文献+

慢性阻塞性肺疾病合并支气管肺癌的临床诊断研究 被引量:2

Clinical diagnostic research of chronic obstructive pulmonary disease complicated with bronchogenic carcinoma
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)与支气管肺癌的临床关系,为临床早期诊断和治疗提供依据。方法 54例COPD合并支气管肺癌患者作为观察组,同期54例单纯肺癌患者作为对照组,比较两组患者临床症状和体征、病理类型及治疗方法的差异。结果两组患者干咳、声音嘶哑、胸膜腔积液及骨痛例数比较差异均无统计学意义(P>0.05),观察组发热、胸痛、痰中带血、呼吸困难及肺不张例数均显著多于对照组(P<0.05);两组鳞癌病理类型比较差异无统计学意义(P>0.05),腺癌、小细胞癌及其他非小细胞癌类型,两组比较差异有统计学意义(P<0.05);观察组以非手术治疗为主,对照组以手术治疗为主。结论 COPD合并支气管肺癌的临床症状缺乏特异性,COPD患者出现胸痛、咯血、呼吸困难或伴肺不张、胸腔积液等影像学表现时,应高度警惕合并肺癌可能,尽早进行初筛检查。 ObjectiveTo investigate the clinical relationship between chronic obstructive pulmonary disease (COPD) and bronchogenic carcinoma, in order to provide reference for early clinical diagnosis and treatment.MethodsThere were 54 patients of COPD complicated with bronchogenic carcinoma as observation group, and another 54 patients with lung cancer alone as control group. Comparisons were made on the clinical symptoms, signs, pathological types and treatment methods between the two groups.ResultsThe differences of tussiculation, hoarseness, pleural effusion, and ostealgia cases between the two groups had no statistical significance (P〉0.05). The observation group had much more cases of fever, chest pain, blood-stained sputum, dyspnea, and pulmonary atelectasis than the control group (P〈0.05). There was no statistically significant difference of squamous carcinoma pathological type between the two groups (P〉0.05). The difference of adenocarcinoma, small cell carcinoma, and non small cell carcinoma had statistical significance between the two groups (P〈0.05). The observation group was treated mainly by non-surgical method, while the control group received surgical treatment.ConclusionThe clinical characteristics of COPD combined with bronchogenic carcinoma lacks of specificity. The imaging manifestations of chest pain, hemoptysis, dyspnea, pulmonary atelectasis, and pleural effusion of COPD patients show the possibility of complicated lung cancer, and early screening examination is necessary.
作者 陈怡 邓宏伟
出处 《中国实用医药》 2015年第10期25-26,共2页 China Practical Medicine
关键词 慢性阻塞性肺疾病 支气管肺癌 临床关系 Chronic obstructive pulmonary disease Bronchogenic carcinoma Clinical relationship
  • 相关文献

参考文献7

二级参考文献61

  • 1Sbepberd FA, Rodrigues Pereia J, Ciuleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer[ J]. N Engl J Med,2005,353 (2) :123-132.
  • 2Wheatley-Price P, Ding K, Seymour L, et al. Erlotinib for advanced non-small-cell lung cancer in elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR. 21 [ J]. J Clin Oncol,2008,26(14) :2350-2357.
  • 3Azzoli CG, Park BJ, Pao W, et al. Molecularly tailored adjuvant chemtherapy for resected non-small cell lung cancer a time for excitement and equipoise[ J]. J Thorac Oncol,2008,3( 1 ) :84-93.
  • 4Merimsky O,Cheng CK, Reck M,et al. Erlotinib :evaluation as a firstline treatment option for elderly patients with advanced non-small-cell lung cancer ( NSCLC ) [ J ]. Crit Rev Oncol/Hematol,2008,68 ( 3 ) : 526.
  • 5中华医学会呼吸病分会慢性阻塞性肺疾病组.慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2007,25(1):453.
  • 6Billich C,Mucher R,Brenner G,et al.CT-guided lung biopsy:incidence of pneumothorax after instillation of NaC1 into the biopsy track.Eur Radiol,2008,18:1146-1152.
  • 7Atwell TD,Smith RL,Hesley GK,et al.Incidence of bleeding after 15,181 percutaneous biopsies and role of aspirin.AJR Am J Roentgenol,2010,194:784-789.
  • 8Yeow KM,Su IH,Pan KT,et al.Risk factors of pneumothorax and bleeding:multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies.Chest,2004,126:748-754.
  • 9Tomiyama N,Yasuhara Y,Nakajima Y,et al.CT-guided needle biopsy of lung lesions:a survey of severe complication based on 9783 biopsies in Japan.Eur J Radiol,2006,59:60-64.
  • 10Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is in- creased in lung cancer, independent of age, sex ang smoking history[J]. EUR Respir J,2009,34 (2): 380-386.

共引文献65

同被引文献13

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部